Tag: Momenta Pharmaceuticals

  • NASDAQ New Lows: Array Biopharma Inc (NASDAQ:ARRY), Momenta Pharmaceuticals (NASDAQ:MNTA), Ceres Inc (NASDAQ:CERE), Mitek Systems (NASDAQ:MITK)

    Array Biopharma Inc (NASDAQ:ARRY) issued a press release announcing that Array reported full results from a randomized Phase 2 trial of ARRY-502 in patients with mild to moderate Th2-Driven Asthma at the 2014 American Academy Of Allergy, Asthma & Immunology Annual Meeting. Array Biopharma Inc (NASDAQ:ARRY) shares after opening at $4.46 moved to $4.52 on last trade day and at the end of the day closed at $4.17. Company price to sales ratio in past twelve months was calculated as 8.21 and price to cash ratio as 4.37. Array Biopharma Inc (NASDAQ:ARRY) showed a negative weekly performance of -6.71%.

    Momenta Pharmaceuticals Inc (NASDAQ:MNTA) saw a big move last session, as the company’s shares fell by nearly 17% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for MNTA as the stock is now down over 28% since March 19. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares advanced 1.26% in last trading session and ended the day on $11.25. MNTA return on equity ratio is recorded as -52.90% and its return on assets is -46.00%. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) yearly performance is -12.79%.

    Shares of Ceres (NASDAQ:CERE) were the recipient of a significant decrease in short interest in January. As of March 14th, there was short interest totalling 361,653 shares, a decrease of 49.7% from the February 28th total of 719,516 shares, ARNreports. Ceres Inc (NASDAQ:CERE) shares moved down -3.70% in last trading session and was closed at $0.780 while trading in range of $0.75 – $0.83 – Ceres Inc (NASDAQ:CERE) year to date (YTD) performance is -43.47%.

    Mitek Systems, Inc (Nasdaq:MITK) announced that it has hit a new milestone with over 2,000 financial institutions signed for Mobile Deposit. Mitek Systems, Inc. (NASDAQ:MITK) weekly performance is -2.98%. On last trading day company shares ended up $3.58. Mitek Systems, Inc. (NASDAQ:MITK) distance from 50-day simple moving average (SMA50) is -29.36%. Analysts mean target price for the company is $6.38.